Transverse Versus Longitudinal Groin Incision in Vascular Surgery
The Incidence of Surgical Site Complications in Transverse Versus Longitudinal Groin Incision in Vascular Surgery: A Randomized Clinical Trial
1 other identifier
interventional
232
1 country
1
Brief Summary
The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery. The main questions it aims to answer are: Does a transverse incision in the groin lead to fewer surgical site complications than a longitudinal incision? Does a transverse incision lead to fewer readmissions, fewer reoperations, shorter length of hospital stay, and a lower amputation rate. Participants will undergo vascular surgery in the groin with either a transverse or longitudinal incision. The incision type will be selected randomly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
June 27, 2025
March 1, 2025
2.3 years
September 27, 2024
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of surgical site complications
The surgical site complications are defined as follows: * Surgical site infection according to the Szilagy classification: * Dehiscence with separation of the wound edges and exposure of the underlying tissue. * Lymhocele defined as the presence of localized swelling in the groin and verified on ultrasound as an anechoic fluid collection. * Hematoma defined as the presence of localized swelling in the groin with discoloration and verified on ultrasound as an echoic fluid collection.
35 days after the operation
Secondary Outcomes (5)
Reoperation
35 days after the operation
Readmission
35 days
• Length of stay
35 days
Mortality
35 days
Healing of the groin
35 days
Study Arms (2)
Transverse groin incision
EXPERIMENTALLongitudinal groin incision
ACTIVE COMPARATORInterventions
The transverse incision is made parallel to the inguinal ligament either superiorly or inferiorly to the skin crease directly over the femoral artery. The subcutaneous tissue is dissected in the transverse direction till Scarpaes fascia after which the dissection is performed in the longitudinal direction along the line of the vessels. The lymphatic vessels are spared as much as possible. Any damaged lymph vessels are closed with surgical clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage. In case of difficulty with proper access to the femoral arteries, the incision can be extended either medially, laterally, or vertically.
The longitudinal incision is made directly over the femoral artery from the inguinal ligament. The subcutaneous tissue is dissected along the line of the vessel sparing the lymphatic vessels as much as possible. Any damaged lymph vessels are closed with clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage.
Eligibility Criteria
You may qualify if:
- Patients undergoing vascular reconstruction with a groin incision
You may not qualify if:
- Patients previously operated with a groin incision.
- Patients undergoing operation due to trauma, bleeding, or pseudoaneurysm.
- Patients operated within the first 24 hours of admission.
- If it prior to the operation is deemed necessary with a muscleplasty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kolding Sygehuslead
- Region of Southern Denmarkcollaborator
- University of Southern Denmarkcollaborator
Study Sites (1)
Department of Vascular Surgery - Lillebaelt Hospital
Kolding, 6000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kim Trine Maria Mejnert Jørgensen, MD, PhD
Department of vascular surgery, Kolding Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD-student
Study Record Dates
First Submitted
September 27, 2024
First Posted
October 8, 2024
Study Start
March 1, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
June 27, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share